Skip to main content

Cookies and Privacy

We use cookies to improve your experience on our website. To find out more, read our updated Cookie policy, Privacy policy and Terms & Conditions

velasco99_Sarinya Pinngam  EyeEm_Getty Images_businessmen Sarinya Pinngam/EyeEm/Getty Images

Bipolar Economics

Randomized controlled trials are the flavor of the month in development economics, with their keenest advocates having just been awarded the Nobel Prize. But can this experimental approach really be counted on to produce better economic policies?

LONDON – How can we know if an economic policy is achieving its stated objective? Well, we can create two similar groups, randomly allocate the “treatment” to only one of them and measure the results. By comparing the groups, we will obtain a reliable estimate of how effective the policy is.

This technique, known as randomized controlled trials, or RCTs, had long been used in medicine and social policy. By applying it to development economics, Esther Duflo, Abhijit Banerjee, and Michael Kremer revolutionized how many economists work – and won the Nobel Prize last month.

The achievement was both intellectual and organizational: a global community of randomistas has emerged, committed to using RCTs to change the world. New evidence would cause developing-country governments to discard bad policies and adopt good ones.

We hope you're enjoying Project Syndicate.

To continue reading, subscribe now.


Get unlimited access to PS premium content, including in-depth commentaries, book reviews, exclusive interviews, On Point, the Big Picture, the PS Archive, and our annual year-ahead magazine.;
  1. op_twliu1_XinhuaXiao Yijiu via Getty Images_wuhancoronavirushospitaldoctor Xinhua/Xiao Yijiu via Getty Images
    Free to read

    Witnessing Wuhan

    Tracy Wen Liu

    While Chinese authorities have been projecting an image of national triumph over the COVID-19 outbreak there, the doctors and nurses on the front lines tell a different story. Having lived through hell, they see little to celebrate, much to mourn, and reason to remain fearful.


Edit Newsletter Preferences